Phase II study of 3-hour infusion of paclitaxel in patients with previously untreated non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Furuse, K
Naka, N
Ariyoshi, Y
Ikegami, H
Fukuoka, M
Yamakido, M
机构：
[1] NATL SANAT KINKI CENT HOSP,DEPT INTERNAL MED,OSAKA,JAPAN
[2] AICHI CANC CTR HOSP,DEPT CARDIOPULM DIS,AICHI,JAPAN
[3] OSAKA PREFECTURAL MED CTR ADULT DIS,DEPT INTERNAL MED 4,OSAKA,JAPAN
[4] HIROSHIMA UNIV,DEPT INTERNAL MED 2,HIROSHIMA,JAPAN
[5] OSAKA CITY GEN HOSP,DEPT PULM MED,OSAKA,JAPAN
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1072 / 1072
页数：1
相关论文
共 50 条
  • [1] Phase II study of 3-hour infusion of paclitaxel in previously untreated non-small cell lung cancer
    Sekine, I
    Nishiwaki, Y
    Watanabe, K
    Yoneda, S
    Saijo, N
    CLINICAL CANCER RESEARCH, 1996, 2 (06) : 941 - 945
  • [2] Phase II study of 3-hour infusion of paclitaxel in patients with previously untreated stage III and IV non-small cell lung cancer
    Furuse, K
    Naka, N
    Takada, M
    Kinuwaki, E
    Kudo, S
    Takada, Y
    Yamakido, M
    Yamamoto, H
    Fukuoka, M
    Ryu, S
    Hara, N
    Takahara, J
    Higashino, K
    Hoso, T
    Araki, J
    Igarashi, T
    Tanio, Y
    Nishikawa, H
    Asamoto, H
    Nakano, M
    Sawa, T
    Ariyoshi, Y
    Ikegami, H
    Nakajima, S
    Senda, H
    ONCOLOGY, 1997, 54 (04) : 298 - 303
  • [3] Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer
    Millward, MJ
    Bishop, JF
    Friedlander, M
    Levi, JA
    Goldstein, D
    Olver, IN
    Smith, JG
    Toner, GC
    Rischin, D
    Bell, DR
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) : 142 - 148
  • [4] Paclitaxel (3-hour infusion) followed by carboplatin (24 hours after paclitaxel): A phase II study in advanced non-small cell lung cancer
    Roychowdhury, DF
    Desai, P
    Zhu, YW
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 37 - 40
  • [5] Phase I study of paclitaxel on a 3-hour schedule followed by carboplatin in untreated patients with stage IV non-small cell lung cancer
    Rowinsky, EK
    Flood, WA
    Sartorius, SE
    Bowling, KM
    Ettinger, DS
    INVESTIGATIONAL NEW DRUGS, 1997, 15 (02) : 129 - 138
  • [6] Phase I study of paclitaxel on a 3-hour schedule followed by carboplatin in untreated patients with stage IV non-small cell lung cancer
    Eric K. Rowinsky
    William A. Flood
    Susan E. Sartorius
    Kathy M. Bowling
    David S. Ettinger
    Investigational New Drugs, 1997, 15 : 129 - 138
  • [7] Phase II study of patients with metastatic nonsmall cell carcinoma of the lung treated with paclitaxel by 3-hour infusion
    Tester, WJ
    Jin, PY
    Reardon, DH
    Cohn, JB
    Cohen, MH
    CANCER, 1997, 79 (04) : 724 - 729
  • [8] PHASE-I STUDY OF PACLITAXEL AS A 3-HOUR INFUSION FOLLOWED BY CARBOPLATIN IN UNTREATED PATIENTS WITH STAGE-IV NON-SMALL-CELL LUNG-CANCER
    ROWINSKY, EK
    FLOOD, WA
    SARTORIUS, SE
    BOWLING, MK
    WAGNER, J
    ETTINGER, DS
    SEMINARS IN ONCOLOGY, 1995, 22 (04) : 48 - 54
  • [9] A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancer
    Bhatia, S
    Hanna, N
    Ansari, R
    Pletcher, W
    Einhorn, L
    Ng, E
    Sandler, A
    LUNG CANCER, 2002, 38 (01) : 73 - 77
  • [10] Phase II study of a one hour paclitaxel infusion in combination with carboplatin for advanced non-small cell lung cancer
    Evans, WK
    Earle, CC
    Stewart, DJ
    Dahrouge, S
    Tomiak, E
    Goss, G
    Logan, D
    Goel, R
    Gertler, SZ
    Dulude, H
    LUNG CANCER, 1997, 18 (01) : 83 - 94
12345